Cargando…

PVR (CD155) Expression as a Potential Prognostic Marker in Multiple Myeloma

Poliovirus receptor (PVR, CD155) is upregulated during tumor progression, and PVR expression is associated with poor prognosis in cancer patients; however, prognostic implications for PVR in multiple myeloma (MM) have not been investigated. PVR plays an immunomodulatory role by interacting with CD22...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Byung-Hyun, Kim, Ji-Hea, Kang, Ka-Won, Lee, Se-Ryeon, Park, Yong, Sung, Hwa-Jung, Kim, Byung-Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139015/ https://www.ncbi.nlm.nih.gov/pubmed/35625835 http://dx.doi.org/10.3390/biomedicines10051099

Ejemplares similares

Myeloma prognostic index at diagnosis might be a prognostic marker in patients newly diagnosed with multiple myeloma
por: Kim, Dae Sik, et al.
Publicado: (2017)

Prediction Model for Cereblon Expression in Bone Marrow Plasma Cells Based on Blood Markers in Multiple Myeloma Patients
por: Lee, Byung-Hyun, et al.
Publicado: (2021)

Prognostic Value of Galectin-9 Relates to Programmed Death-Ligand 1 in Patients With Multiple Myeloma
por: Lee, Byung-Hyun, et al.
Publicado: (2021)

The effect of the response to the coronavirus disease pandemic on treatment outcomes in patients with lymphoma and multiple myeloma
por: Kang, Ka-Won, et al.
Publicado: (2021)

Modified dose of melphalan-prednisone in multiple myeloma patients receiving bortezomib plus melphalan-prednisone treatment
por: Lee, Se Ryeon, et al.
Publicado: (2019)

Bortezomib and melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma
por: Lee, Se Ryeon, et al.
Publicado: (2010)

Acetate decreases PVR/CD155 expression via PI3K/AKT pathway in cancer cells
por: Tran, Na Ly, et al.
Publicado: (2021)

Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation
por: Fionda, Cinzia, et al.
Publicado: (2015)

Prognostic outcomes of cytomegalovirus reactivation after autologous stem cell transplantation
por: Lee, Byung-Hyun, et al.
Publicado: (2023)

CD155/PVR plays a key role in cell motility during tumor cell invasion and migration
por: Sloan, Kevin E, et al.
Publicado: (2004)

Comparison between 5-day decitabine and 7-day azacitidine for lower-risk myelodysplastic syndromes with poor prognostic features: a retrospective multicentre cohort study
por: Lee, Byung-Hyun, et al.
Publicado: (2020)

Identification of PVR (CD155) and Nectin-2 (CD112) as Cell Surface Ligands for the Human DNAM-1 (CD226) Activating Molecule
por: Bottino, Cristina, et al.
Publicado: (2003)

PD-L1 expression in bone marrow plasma cells as a biomarker to predict multiple myeloma prognosis: developing a nomogram-based prognostic model
por: Lee, Byung-Hyun, et al.
Publicado: (2020)

Efficacy and safety of two pegfilgrastim biosimilars: Tripegfilgrastim and pegteograstim
por: Kang, Ka‐Won, et al.
Publicado: (2020)

Efficacy of posaconazole prophylaxis in acute myeloid leukemia and myelodysplastic syndrome patients treated with hypomethylating agents
por: Kang, Ka-Won, et al.
Publicado: (2020)

Cytomegalovirus reactivation under pre-emptive therapy following allogeneic hematopoietic stem cell transplant: Pattern, survival, and risk factors in the Republic of Korea
por: Kang, Ka-Won, et al.
Publicado: (2023)

Immature platelet fraction based diagnostic predictive scoring model for immune thrombocytopenia
por: Jeon, Min Ji, et al.
Publicado: (2020)

Postoperative Thromboembolism According to the Type of Surgery: A Nationwide Study in the Republic of Korea
por: Kang, Ka-Won, et al.
Publicado: (2022)

Supporting data on enhanced reprogramming of human CD34+ hematopoietic stem cells to induced pluripotent stem cells using human placenta-derived cell conditioned medium
por: Lee, Seung-Jin, et al.
Publicado: (2020)

The role of platelet function analyzer-200 in predicting perioperative bleeding risk
por: Yu, Eun Sang, et al.
Publicado: (2020)

A nationwide study of patients with monoclonal gammopathy of undetermined significance with a 10-year follow-up in South Korea
por: Kang, Ka-Won, et al.
Publicado: (2021)

CXCR2 inhibition overcomes ponatinib intolerance by eradicating chronic myeloid leukemic stem cells through PI3K/Akt/mTOR and dipeptidylpeptidase Ⅳ (CD26)
por: Kim, Ji-Hea, et al.
Publicado: (2023)

Lack of usefulness of computed tomography for surveillance in patients with aggressive non-Hodgkin lymphoma
por: Kang, Ka-Won, et al.
Publicado: (2018)

Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option
por: Stamm, Hauke, et al.
Publicado: (2018)

Cancer-associated fibroblast suppresses killing activity of natural killer cells through downregulation of poliovirus receptor (PVR/CD155), a ligand of activating NK receptor
por: Inoue, Tomoko, et al.
Publicado: (2016)

Clinicopathological characteristics of extremely young Korean multiple myeloma patients: therapeutic implications
por: Shin, Junghoon, et al.
Publicado: (2017)

Biomarkers for PVR in rhegmatogenous retinal detachment
por: Zandi, Souska, et al.
Publicado: (2019)

PVR—A Prognostic Biomarker Correlated with Immune Cell Infiltration in Hepatocellular Carcinoma
por: Liu, Wen-Feng, et al.
Publicado: (2022)

Soluble CD147 (BSG) as a Prognostic Marker in Multiple Myeloma
por: Łacina, Piotr, et al.
Publicado: (2022)

CD24 Is a Prognostic Marker for Multiple Myeloma Progression and Survival
por: Gross Even-Zohar, Noa, et al.
Publicado: (2022)

BCL2 as a Subtype-Specific Prognostic Marker for Breast Cancer
por: Eom, Yong Hwa, et al.
Publicado: (2016)

TIGIT-CD226-PVR axis: advancing immune checkpoint blockade for cancer immunotherapy
por: Chiang, Eugene Y, et al.
Publicado: (2022)

Managing PVR in the Era of Small Gauge Surgery
por: Nagpal, Manish, et al.
Publicado: (2021)

Successful treatment of disseminated interdigitating dendritic cell sarcoma with adriamycin, bleomycin, vinblastine, and dacarbazine chemotherapy
por: Lee, Suk-young, et al.
Publicado: (2012)

BK virus encephalitis without concurrent hemorrhagic cystitis in an allogeneic hematopoietic stem cell transplant recipient
por: Lee, Suk-young, et al.
Publicado: (2013)

Targeted eicosanoids profiling reveals a prostaglandin reprogramming in breast Cancer by microRNA-155
por: Kim, Sinae, et al.
Publicado: (2021)

The roles of signaling pathways in epithelial-to-mesenchymal transition of PVR
por: Chen, Zhenna, et al.
Publicado: (2015)

Dealings between Cataract and Retinal Reattachment Surgery in PVR
por: Deuchler, Svenja, et al.
Publicado: (2016)

Targeting the “PVR–TIGIT axis” with immune checkpoint therapies
por: Gorvel, Laurent, et al.
Publicado: (2020)

Infographic: Slow-release dexamethasone in proliferative vitreoretinopathy (PVR)
por: Mostafa, I., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8bt5cl3n53p6nu9rppbihmlk28